According to a new study, the Astrazeneca vaccine is 76% effective against symptomatic disease and 100% effective against severe disease. The study was conducted in the US, The Washington Post reported.
Astrazeneca also reported that the vaccine showed 86% efficacy in people who are 65 and older.
A few days ago, the interim results of this study were published, which stated that the Astrazeneca vaccine is 76% effective in preventing symptomatic disease. The study involved 32 449 people from the US, Chile, and Peru.